Myocardial integrated ultrasonic backscatter in patients with dilated cardiomyopathy: Prediction of response to β-blocker therapy

American Heart Journal

Volumn 139, Issue 5, 2000, Pages 905-912

  Suwa, Michihiro ^a   Ito, Takahide ^b   Kobashi, Ayaka ^b   Yagi, Hatsumi ^b   Terasaki, Fumio ^b   Hirota, Yuzo ^b   Kawamura, Keishiro ^b  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG RESPONSE; ECHOCARDIOGRAPHY; FEMALE; HEART DILATATION; HEART MUSCLE BIOPSY; HUMAN; IMAGE ANALYSIS; MALE; PRIORITY JOURNAL; ULTRASOUND;

EID: 0034027116     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(00)90024-3     Document Type: Article

References (29)

1. 1. Waagstein F, Hjalmarson A, Varnauskas E, et al. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975;37:1022-36.
2. 2. Swedwerg K, Hjalmarson A, Waagstein F, et al. Beneficial effects of long-term beta-blockade in congestive cardiomyopathy Br Heart J 1980;44:117-33.
3. 3. MERIT-HF study group. Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL randomised intervention trial in congestive heart failure (MERIT-HF). Lancet 1999;353:2001-7.
4. 4. CIBIS-II investigators and committees. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial. Lancet 1999;353:9-13.
5. 5. Packer M, Bristow MR, Cohn JN, et al for the U.S. Carvedilol Heart Failure study group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55.
6. 6. Yamada T, Fukunami M, Ohmori M, et al. Which subgroup of patients with dilated cardiomyopathy would benefit from long-term beta-blocker therapy? A histologie viewpoint, J Am Coll Cardiol 1993; 21:628-33.
7. 7. Masuyama T, Nellessen U, Schnittger I, et al. Ultrasonic tissue characterization with a real time integrated backscatter imaging system in normal and aging human hearts. J Am Coll Cardiol 1989; 14:1702-8.
8. 8. Milunski MR, Mohr GA, Wear KA, et al. Early identification with ultrasonic integrated backscatter of viable but stunned myocardium in dogs. J Am Coll Cardiol 1989; 14:462-71.
9. 9. Milunski MR, Mohr GA, Perez JE, et al. Ultrasonic tissue characterization with integrated backscatter. Acute myocardial ischemia, reperfusion, and stunned myocardium in patients. Circulation 1989;80:491-503.
10. 10. Takiuchi S, Ito H, Iwakura K, et al. Ultrasonic tissue characterization predicts myocardial viability in early stage of reperfused acute myocardial infarction. Circulation 1998,97:356-62.
11. 11. Masuyama T, St Goar FG, Tye TL, et al. Ultrasonic tissue characterization of human hypertrophied hearts in vivo with cardiac cycle-dependent variation in integrated backscatter. Circulation 1989;80:925-34.
12. 12. Vitale DF, Bonow RO, Calabro R, et al. Myocardial ultrasonic tissue characterization in pediatric and adult patients with hypertrophic cardiomyopathy. Circulation 1996;94:2826-30.
13. 13. Naito J, Masuyama T, Mono T, et al. Ultrasonic myocardial tisssue characterization in patients with dilated cardiomyopathy: value in noninvasive assessment of myocardiol fibrosis. Am Heart J 1996, 131:115-21.
14. 14. Naito J, Masuyama T, Tanouchi J, et al. Analysis of transmural trend of myocardial integrated ultrasound backscatter for differentiation of hypertrophic cardiomyopathy and ventricular hypertrophy due to hypertension. J Am Coll Cardiol 1994;24:517-24.
15. 15. Angermann CE, Nassau K, Stempfle H-U, et al. Recognition of acute cardiac allograft rejection from serial integrated backscatter analyses in human orthotopic heart transplant recipients. Comparison with conventinal echocardiography. Circulation 1997;95:140-50.
16. 16. Weibel ER. Point counting methods. In: Weibel ER editor. Stereological methods. London: Academic Press; 1979. p. 101-61.
17. 17. Suwa M, Otake Y, Moriguchi A, et al. Iodine 123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to β-blocker therapy in patients with dilated cardiomyopathy. Am Heart J 1997;133:353-8.
18. 18. Sogar KB, Pelc LE, Rhyne TL, et al. Influence of heart rate, preload, afterload, and inotropic state on myocardial ultrasonic backscatter. Circulation 1988:77:478-83.
19. 19. Wickline SA, Thomas LJ III, Miller JG, et al. The dependence of myocardial ultrasonic integrated backscatter on contractile performance. Circulation 1985;72:183-92.
20. 20. Pasquet A, D'Hondt A-M, Melin JA, et al. Relation of ultrasonic tissue characterization with integrated backscatter to contractile reserve in chronic left ventricular ischemic dysfunction. Am J Cardiol 1998;81 68-74.
21. 21. Bouki KP, Lange A, Palla P, et al. Regional variations of ultrasonic integrated backscatter in normal and myopathic left ventricles. A new multi-view approach. Eur Heart J 1996; 17:1747-55.
22. 22. Vered Z, Barzilai B, Mohr GA, et al. Quantitative ultrasonic tissue characterization with real-time integrated backscatter imaging in normal human subjects and in patients with dilated cardiomyopathy. Circulation 1987;76:1067-73.
23. 23. Hoyl RM, Skorton DJ, Collins SM, et al. Ultrasonic backscatter and collagen in normal ventricular myocardium. Circulation 1984;69: 775-82.
24. 24. Hoyt RH, Collins SM, Skorton DJ, et al. Assessment of fibrosis in infarcted human hearts by analysis of ultrasonic backscatter. Circulation 1985;71:740-4.
25. 25. Naito J, Masuyama T, Yamamolo K, etal. Myocardial integrated ultrasonic backscatter in patients with old myocardial infarction: comparison with radionuclide evaluation. Am Heart J 1996;132:54-60.
26. 26. Belle VD, Talarico L, Picano E, et al. Increased myocardial echo density in left ventricular pressure and volume overload in human aortic valvular disease: an ultrasonic tissue characterization study, J Am Soc Echocardiogr 1997; 10:320-9.
27. 27. Wong AK, Verdonk ED, Hoffmeister BK, et al. Detection of unique transmural architecture of human idiopathic cardiomyopathy by ultrasonic tissue characterization. Circulation 1992;86:1108-15.
28. 28. Streeter DD Jr, Spotnitz HM, Patel DP, et al. Fiber orientation in the canine left ventricle during diastole and systole. Circ Res 1969;24: 339-47.
29. 29. Picano E, Pelosi G, Morzilli M, et al. In vivo quantitative ultrasonic evaluation of myocardial fibrosis in humans. Circulation 1990; 81:58-64.